Official-source baseline for Ascentage Pharma using SEC submissions, FY2025 Form 20-F, SEC companyfacts, company-filed FY2025 results releases, ASCO 2026 update, annual meeting materials, and oncology peer filings.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.
